News

Date Category Title
05/07/2017 Press Releases Horizon Discovery Takes Exclusive License for Novel Transposon-Based Gene Editing Technology Platform View
03/07/2017 Press Releases Horizon Discovery announces inclusion of its Reference Standards in successful FDA approval of an oncology companion diagnostic test with leading next generation sequencing company View
29/06/2017 Press Releases Abcam plc Exercises Exclusivity Provision of License and Supply Agreement with Horizon Discovery View
15/06/2017 Press Releases Horizon Discovery’s RNA reference standards endorsed by Thermo Fisher Scientific’s White Paper for use in cancer research testing View
14/06/2017 Press Releases Horizon Discovery Announces Progress of its Gene and Cell Therapy Platform for Contract Service and Therapeutic Applications View
01/06/2017 Press Releases ATUM and Horizon Discovery Announce Collaboration and Technology Cross-License to Simplify and Speed Bioproduction Cell Line Development View
26/05/2017 Press Releases Horizon Discovery introduces four BRAF resistant melanoma PDX models View
22/05/2017 Press Releases Horizon Discovery Announces New Gene Editing Technology Platform for Research and Therapeutic Applications View
09/05/2017 Press Releases Horizon Discovery Announces Update on its Immuno-Oncology Platform including Strong Uptake of Product and Service Offerings View
11/04/2017 Press Releases Horizon Discovery Group Comment on the Acquisition of Agalimmune by BioLineRx with Read Across to Avvinity Therapeutics View

21-30 of 265

Back to top